13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35311230 | Clinical-Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma. | 2022 | 1 |
2 | 35501518 | The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer. | 2022 May 2 | 1 |
3 | 31375570 | The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer. | 2020 Feb | 1 |
4 | 31026111 | TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases. | 2019 Jul | 3 |
5 | 31412230 | MOLECULAR PROFILE AND CLINICAL OUTCOMES IN DIFFERENTIATED THYROID CANCER PATIENTS PRESENTING WITH BONE METASTASIS. | 2019 Dec | 2 |
6 | 29413688 | Predictive factors of outcome in poorly differentiated thyroid carcinomas. | 2018 Mar | 1 |
7 | 27493271 | TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer. | 2017 Feb | 9 |
8 | 26857243 | Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation. | 2016 Feb 9 | 1 |
9 | 25410753 | Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy. | 2015 Jan | 1 |
10 | 24476079 | TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. | 2014 May | 1 |
11 | 22412937 | SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I. | 2012 | 2 |
12 | 21797672 | Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. | 2011 Aug | 2 |
13 | 21801606 | Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells. | 2011 Aug | 2 |